Amerika will Indien mit Astra-Zeneca-Impfstoff helfen faz.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from faz.net Daily Mail and Mail on Sunday newspapers.
23-04-2021 )
Co-initiated by the European Union, the United Nations, the World Health Organisation and many partner organisations from the NGO sector, the global response, the “Access to COVID-19 Tools Accelerator” (ACT-A) was launched exactly one year ago. [Udo Bullmann s office]
The malaria vaccine test raises hopes of overcoming the disease
The test against a new malaria vaccine at Oxford University indicates that it is 77 per cent effective, far better than the existing shots to prevent one of the world’s deadliest diseases.
The owner, known as R21, is the first to be able to pass a vaccine that could exceed the World Health Organization’s goal of at least 75 percent effectiveness by 2030. Mosquirix, the first malaria vaccine to be launched in early 2015, required GSK to take more than 30 years to develop and 39 percent effective for four years.
In phase 2b of R21 – in the middle phase – participants in a group of higher doses were 77% less likely to develop malaria in the 12-month follow-up than those who received a rage as a control. Those who received a lower dose of the vaccine helper were 71 percent less likely to develop the disease. There were no serious side effects.
African Union drops plans to buy additional AstraZeneca vaccine from India s Serum Institute
From CNN s James Frater
Vials of AstraZeneca s Covishield vaccine for COVID-19 are seen at a filling lab at the Serum Institute of India, Pune, India, Thursday, Jan. 21, 2021. Rafiq Maqbool/AP
The African Union has announced it is dropping plans to buy additional doses of the AstraZeneca Covid-19 vaccine directly from the Serum Institute of India and will instead focus on securing further vaccines from Johnson & Johnson.
John Nkengasong, director of the Africa Centres for Disease Control and Prevention (ACDC), said the decision was not related to recent safety concerns over the AstraZeneca vaccine but “because we work very closely with COVAX,” the vaccine-sharing facility for the world’s poorest countries.
Allocations of Johnson & Johnson s Covid-19 vaccine expected to drop 84% next week, data shows
From CNN’s Deidre McPhillips
A medical worker with Northwell Health holds up doses of the Johnson & Johnson coronavirus (COVID-19) vaccine at the Northwell Health pop-up coronavirus (COVID-19) vaccination site at the Albanian Islamic Cultural Center in Staten Island on April 08, 2021 in New York City. Michael M. Santiago/Getty Images
The number of Johnson & Johnson Covid-19 vaccine shots allocated to states and other jurisdictions by the federal government is expected to drop 84% next week, according to data from the US Centers for Disease Control and Prevention.
This week, nearly 5 million doses of the Johnson & Johnson vaccine were allocated to states and other jurisdictions, but only about 785,000 are slated for next week.